These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83. Stewart GT Dev Biol Stand; 1985; 61():395-405. PubMed ID: 3835080 [TBL] [Abstract][Full Text] [Related]
88. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. Zackrisson G; Taranger J; Trollfors B J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488 [TBL] [Abstract][Full Text] [Related]
89. The epidemiological situation of pertussis in the Federal Republic of Germany. Finger H; Wirsing von König CH; Tacken A; Wassilak SG Dev Biol Stand; 1991; 73():343-55. PubMed ID: 1778329 [TBL] [Abstract][Full Text] [Related]
90. Whooping cough (pertussis): FactSheet. N S W Public Health Bull; 2000 Nov; 11(11):193. PubMed ID: 12105536 [No Abstract] [Full Text] [Related]
91. [Pertussis (Whooping cough)--an update]. Stock I Med Monatsschr Pharm; 2015 Dec; 38(12):484-8. PubMed ID: 26837155 [TBL] [Abstract][Full Text] [Related]
92. Development of improved vaccines against whooping cough: current status. Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470 [TBL] [Abstract][Full Text] [Related]
93. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]